Radial Compression Devices Market: Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2022-2031

 The Global Radial Compression Devices Market is predicted to rise rapidly during the forecast period, according to a recent analysis by Future Market Insights (FMI). The market is predicted to expand from 213.7 million USD in 2021 to almost 504.0 million USD by 2031. This corresponds to a cumulative CAGR of approximately 9.0% for the anticipated period (2022-2031).

A radial compression device is a band that is placed around the wrist to lessen the risk of radial artery blockage following invasive cardiac operations. This device is used to stop bleeding following an angiography or angioplasty procedure.

 

In recent years, the global market for radial compression devices has greatly evolved. These have been strengthened by the development of technology that accelerate the time it takes to reach hemostasis, enhance the process, and lower the risk of radial artery occlusion (RAO). RAO concerns have been a major source of worry when accessing the transracial artery for cardiac catheterization, resulting in the development of the radial compression device market.


For the compression of the radial artery, a variety of contact radial compression devices have been employed, particularly following a transradial procedure in coronary angiography.


Growing number of percutaneous coronary intervention procedures (PCI), acceptance of compression devices for surgical and diagnostic cardiology interventions, new product launches and approvals – leading to greater availability in both established and emerging economies are factors driving the growth of radial compression devices market.


Furthermore, the advantages of radial access in a percutaneous coronary intervention (PCI) procedure are expected to drive the market growth. Radial access allows patients to move more quickly, the incision is smaller, and the chances of infection at the site are much lower than with trans-femoral access.

 

Access Full Report: https://www.futuremarketinsights.com/reports/radial-compression-device-market

 

Key Takeaways from Radial Compression Device Study

·         Band/Strap based products provides rigid wrist support, and improved patient comfort which leads the segment to account for the maximum share of  79.8% in 2021, expanding at 9.7% CAGR during the forecast period.

·         Disposable devices accounted for 92.9% of the market share in 2021 indicating highest demand by usage segment due to ease in use and cost effective and being mainly used in gaining and maintaining the hemostasis of the radial.

·         With the increasing diagnosis rather than surgical intervention the diagnostic intervention, by application held the largest share of 50.5% in 2021 and is expected to grow with the same trend by 2031.

·         Independent catheterization centers are preferred choices with highly favorable settings for diagnosis and treatment and leads it to account for the highest share of around 41.7% of the end user segment.

·         North America held the largest share of 40.5% of the global radial compression devices market in 2021 indicating the growth due to geriatric population and growing demand for advanced medical technology in North America.


“Increasing use of radial compression devices in percutaneous coronary intervention procedures (PCI), due to rising cardiovascular disorders to drive the demand of radial compression over the Decade,” says the FMI Analyst

Key Companies Profiled:

  • Terumo Corporation
  • Merit Medical Inc.
  • Abbott Laboratories
  • Vascular Solutions
  • ConMed B.V.
  • Cardinal Health
  • Beijing Demax Medical Technology
  • Teleflex Incorporated
  • Forge Medical Inc.
  • TZ Medical Inc
  • Semler Technologies Inc
  • Advanced Vascular Dynamics
  • MedPlus, Inc.
  • Lepu Medical

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more